综合性基因组分析确定MITF是一种在恶性黑色素瘤中被放大的血统生存瘤基因
Levi A Garraway1, Hans R Widlund, Mark A Rubin
1Department of Medical Oncology, and Melanoma Program in Medical Oncology, Dana-Farber Cancer Institute, 44 Binney Street, Boston, Massachusetts 02115, USA.
Nature
|July 8, 2005
概括
微眼症相关转录因子 (MITF) 放大驱动黑色素瘤的进展,并减少患者的存活率. 针对MITF为这种耐化疗癌症提供了潜在的治疗策略.
科学领域:
- 基因组学就是基因组学.
- 癌症生物学 癌症生物学
- 分子瘤学分子瘤学
背景情况:
- 癌症基因组分析揭示了导致瘤发展的遗传变化.
- 单核酸多态系 (SNP) 阵列可以识别拷贝数的变化和异构性丧失事件.
研究的目的:
- 在黑色素瘤中识别新的遗传变异.
- 研究MITF在黑色素瘤起源和进展中的作用.
- 探索针对MITF的治疗策略.
主要方法:
- 集成的SNP阵列数据与来自NCI60细胞系的基因表达特征.
- 分析了MITF放大患病率及其与临床结果的相关性.
- 在人类初级黑色素细胞中利用了宫外MITF表达和BRAF (V600E) 突变.
- 评估了MITF降低对化学敏感性的影响.
主要成果:
- 确定了MITF放大作为一种新的黑色素瘤瘤基因.
- 在转移性黑色素瘤中,MITF放大更频繁,并且与较差的生存率有关.
- MITF放大与BRAF突变和p16无活化同时发生.
- 宫外MITF表达与BRAF (V600E) 转变的黑色素细胞.
- 减少MITF活动使黑色素瘤细胞对化疗敏感.
结论:
- MITF作为黑色素瘤瘤基因和"血统生存"因素起作用.
- MITF放大是黑色素瘤进展和转移的关键驱动因素.
- 针对MITF,可能使用BRAF或CDK抑制剂,为黑色素瘤提供了一个有前途的治疗方法.
相关概念视频
Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Abnormal Proliferation
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Tumor Microenvironment
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
mTOR Signaling and Cancer Progression
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
Cancer-Critical Genes II: Tumor Suppressor Genes
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...


